Richards, Merrill & Peterson’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$858K Sell
9,460
-979
-9% -$89.4K 0.27% 92
2026
Q1
$1.07M Buy
10,439
+871
+9% +$98.3K 0.39% 65
2025
Q4
$1.2M Buy
9,568
+1,892
+25% +$241K 0.46% 58
2025
Q3
$1.03M Sell
7,676
-36
-0.5% -$4.73K 0.44% 57
2025
Q2
$1.05M Buy
7,712
+804
+12% +$106K 0.5% 53
2025
Q1
$916K Buy
6,908
+482
+8% +$61.3K 0.48% 55
2024
Q4
$727K Buy
+6,426
New +$743K 0.38% 69

Other funds holding ABT

Richards, Merrill & Peterson's ABT Position: Q2 2026 in Review

Richards, Merrill & Peterson reduced its Abbott (ABT) stake by 9.4% in Q2 2026, selling an estimated $89.4K and leaving 9,460 shares worth $858K. The position accounts for 0.27% of the portfolio, ranked #92.

Richards, Merrill & Peterson first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.2M in Q4 2025. 1,385 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Richards, Merrill & Peterson held 9,460 shares of Abbott worth $858K as of Q2 2026.
  • Richards, Merrill & Peterson sold 979 Abbott shares in Q2 2026, an estimated $89.4K.
  • Abbott made up 0.27% of Richards, Merrill & Peterson's portfolio in Q2 2026, its #92 holding.
  • Richards, Merrill & Peterson first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Richards, Merrill & Peterson's Abbott position peaked at $1.2M in Q4 2025.
  • 1,385 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2026, filed 16 Jul 2026.